Megace Es
NDC Package 16590-254-33
Package Information
Megace Es is iNDICATIONS AND USAGEMegace ® ES (megestrol acetate) oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Marketed by Stat Rx Usa, this product is identified by NDC 16590-254 and is authorized under FDA application NDA021778.
Identification & Billing
- RxCUI: 577154 - megestrol acetate 625 MG in 5 mL Oral Suspension
- RxCUI: 577154 - megestrol acetate 125 MG/ML Oral Suspension
- RxCUI: 577154 - megestrol acetate 625 MG per 5 ML Oral Suspension
- RxCUI: 885111 - MEGACE ES 625 MG in 5 mL Oral Suspension
- RxCUI: 885111 - megestrol acetate 125 MG/ML Oral Suspension [Megace]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 16590 - Stat Rx Usa
- 16590-254 - Megace Es
- 16590-254-33 - 150 mL in 1 BOTTLE
- 16590-254 - Megace Es
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16590-254-33 identifies a specific commercial package of 150 ml in 1 bottle of Megace Es, labeled by Stat Rx Usa. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Stat Rx Usa on June 08, 2005. The current certification is valid through December 31, 2017.
How is this Stat Rx Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16590025433. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.